Antidote Market
According to Intent Market Research, the Antidote Market is expected to grow from USD 2.1 billion in 2023 at a CAGR of 6.2% to touch USD 3.1 billion by 2030. The Antidote Market is dominated by key players such as Mylan N.V. (Viatris), Pfizer Inc., Novartis AG, GlaxoSmithKline Plc, F. Hoffmann-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Fresenius SE & Co. KGaA, Johnson & Johnson (Janssen Pharmaceuticals), Boehringer Ingelheim International GmbH, Dr. Reddy’s Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Hikma Pharmaceuticals PLC, Zydus Lifesciences (Cadila Healthcare), Mallinckrodt Pharmaceuticals, CSL Limited.